We are live on ! Find out more
Pathstone Holdings

Pathstone Holdings Portfolio holdings

AUM $34.3B Turnover 12.6%
1-Year Est. Return 27.35%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+27.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.5B
AUM Growth
+$2.82B
Cap. Flow
+$1.32B
Cap. Flow %
6.14%
Top 10 Hldgs %
31.17%
Holding
2,376
New
177
Increased
1,470
Reduced
542
Closed
80
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.84%
2 Technology 15.77%
3 Financials 9.68%
4 Consumer Discretionary 5.77%
5 Healthcare 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CBOE icon
2276
CALL
Cboe Global Markets
CBOE
$32.9B
$31.6K ﹤0.01%
+1,300
New +$240K
2024 Q1
0 quarters
GSAT icon
2277
Globalstar
GSAT
$10.7B
$31.3K ﹤0.01%
+1,419
New +$34.4K
2024 Q1
0 quarters
UP icon
2278
Wheels Up
UP
$126M
$31.1K ﹤0.01%
542
-57
-10% -$3.75K
2023 Q4
1 quarter
ELDN icon
2279
Eledon Pharmaceuticals
ELDN
$173M
$26.8K ﹤0.01%
13,029
– –
2023 Q4
1 quarter
ABUS icon
2280
Arbutus Biopharma
ABUS
$836M
$26.2K ﹤0.01%
10,155
– –
2023 Q4
1 quarter
OPI
2281
DELISTED
Office Properties Income Trust
OPI
$25.7K ﹤0.01%
+12,579
New +$43.2K
2024 Q1
0 quarters
IWM icon
2282
CALL
iShares Russell 2000 ETF
IWM
$76.2B
$18.4K ﹤0.01%
+1,000
New +$199K
2024 Q1
0 quarters
FUBO icon
2283
FuboTV Inc
FUBO
$242M
$18.2K ﹤0.01%
+958
New +$25K
2024 Q1
0 quarters
PAAI icon
2284
Paradium.AI, Inc.
PAAI
$40.8M
$18.1K ﹤0.01%
15,345
– –
2023 Q4
1 quarter
XFOR icon
2285
X4 Pharmaceuticals
XFOR
$257M
$17.6K ﹤0.01%
421
– –
2023 Q4
1 quarter
KRON icon
2286
DELISTED
Kronos Bio
KRON
$15.6K ﹤0.01%
11,984
-50
-0.4% -$57
2023 Q4
1 quarter
CLNN icon
2287
Clene
CLNN
$44.1M
$10.7K ﹤0.01%
1,262
– –
2023 Q4
1 quarter
RBOT icon
2288
DELISTED
Vicarious Surgical
RBOT
$10.3K ﹤0.01%
1,141
– –
2023 Q4
1 quarter
TMQ icon
2289
Trilogy Metals
TMQ
$428M
$10K ﹤0.01%
20,000
– –
2023 Q4
1 quarter
QMCO icon
2290
Quantum Corp
QMCO
$728M
$6.1K ﹤0.01%
513
– –
2023 Q4
1 quarter
ALP
2291
Alpha Compute
ALP
$5.27M
$5.69K ﹤0.01%
10
– –
2023 Q4
1 quarter
SENS icon
2292
Senseonics Holdings Inc
SENS
$411M
$5.31K ﹤0.01%
500
-25,000
-98% -$290K
2023 Q4
1 quarter
MRIN
2293
DELISTED
Marin Software
MRIN
$4.35K ﹤0.01%
2,377
– –
2023 Q4
1 quarter
TSLA icon
2294
PUT
Tesla
TSLA
$1.4T
$1.52K ﹤0.01%
+100
New +$19.5K
2024 Q1
0 quarters
DGRO icon
2295
PUT
iShares Core Dividend Growth ETF
DGRO
$44B
$350 ﹤0.01%
+700
New +$38.9K
2024 Q1
0 quarters
SWVLW icon
2296
Swvl Holdings Corp Warrant
SWVLW
$95.9K
$278 ﹤0.01%
16,666
– –
2023 Q4
1 quarter
ACWV icon
2297
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.4B
– –
-2,661
Closed -$267K –
APPF icon
2298
AppFolio
APPF
$7.51B
– –
-1,599
Closed -$277K –
BANF icon
2299
BancFirst
BANF
$3.66B
– –
-3,230
Closed -$314K –
BBDC icon
2300
Barings BDC
BBDC
$884M
– –
-10,531
Closed -$90.4K –

Similar funds

Pathstone Holdings's Q1 2024 Portfolio in Review

As of Q1 2024, Pathstone Holdings held 2,376 positions worth $21.5B, up 15% from $18.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pathstone Holdings deployed $1.32B of net new capital in Q1 2024, opening 177 new positions and adding to 1,470 existing holdings. Its largest new stake was Klaviyo: 161,986 shares worth $4.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was CrowdStrike, an estimated $189M trimmed.

  • Pathstone Holdings's largest Q1 2024 buy was Klaviyo: 161,986 shares worth $4.13M.
  • Pathstone Holdings added most to Berkshire Hathaway Class A in Q1 2024, an estimated $382M increase.
  • Pathstone Holdings's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $189M.
  • Pathstone Holdings fully exited Cognition Therapeutics in Q1 2024, selling an estimated $4.08M.
  • Pathstone Holdings's ten largest holdings make up 31% of its $21.5B portfolio in Q1 2024.
  • Pathstone Holdings opened 177 new positions and closed 80 in Q1 2024.
  • Pathstone Holdings's portfolio value rose 15% quarter-over-quarter to $21.5B.

Based on Pathstone Holdings's 13F filing for Q1 2024, filed 13 May 2024.